Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4932-4938

  Rofstad, E K ^a   Halsor, E F ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MELANOMA; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LYMPHOKINES; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034283023     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Cutaneous melanoma
2. Molecular pathology of melanoma
3. Advances in melanoma therapy
4. Melanoma antigens: Immunological and biological characterization and clinical significance
5. Human melanoma: Development and progression
6. Neovascularization in human cutaneous melanoma: A. quantitative morphological and Doppler ultrasound study
7. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
8. Angiogenesis is prognostically important in vertical growth phase melanomas
9. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
10. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: A. quantitative histologic study
11. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects
12. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
13. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
14. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: Effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts
15. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastases
16. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma
17. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
18. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastases
19. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma
20. Differential metabolism of thymidine in human lymphoid and melanoma cells in vitro
21. Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors
22. bFGF as an autocrine growth factor for human melanoma
23. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
24. Antisense targeting of basic fibroblast growth factor, and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
25. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
26. Vascular endothelial growth factor
27. Interleukin-8 as a macrophage derived mediator of angiogenesis
28. Role of interleukin-8 in tumor growth and metastasis of human melanoma
29. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy
30. Fibroblast growth factors: At the heart of angiogenesis
31. Angiogenesis and metastasis
32. Biological roles of fibroblast growth factor-2
33. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor
34. Autocrine and paracrine roles for growth factors in melanoma. In Vivo
35. Growth factors and melanomas
36. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines
37. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern
38. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
39. VEGF, bFGF and E.G.F. in the angiogenesis of human melanoma xenografts
40. Local tumor control following single dose irradiation of human melanoma xenografts: Relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse
41. Metastatic behavior of human tumors in congenitally athymic nude mice: Intrinsic properties of the tumor cells and host immune reactivity
42. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
43. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
44. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
45. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by E.G.F., PDGF-BB, and bFGF
46. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia
47. Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local turnout control as end points
48. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
49. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker
50. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
51. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
52. Hypoxia-induced metastasis of human melanoma cells: Involvement of vascular endothelial growth factor-mediated angiogenesis
53. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours
54. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma
55. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway
56. The implications of angiogenesis for the biology and therapy of cancer metastasis
57. Vascular density in human melanoma xenografts: Relationship to angiogenesis, perfusion and necrosis
58. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models
59. A synthetic peptide inhibitor for α-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice
60. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
61. Neutralizing antivascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a preclinical model
62. Antitumor and antimetastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice
63. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice